150 related articles for article (PubMed ID: 20608463)
1. [Benign prostatic syndrome (BPS)].
Neubauer S
MMW Fortschr Med; 2010 Jun; 152(23):37-40. PubMed ID: 20608463
[No Abstract] [Full Text] [Related]
2. Benign prostatic hyperplasia.
Barry M; Roehrborn C
Clin Evid; 2002 Jun; (7):775-87. PubMed ID: 12230703
[No Abstract] [Full Text] [Related]
3. Benign prostatic hyperplasia.
Barry M; Roehrborn C; Webber R
Clin Evid; 2002 Dec; (8):849-63. PubMed ID: 12603916
[No Abstract] [Full Text] [Related]
4. [Acute urinary retention in the benign prostatic syndrome].
Gratzke C; Reich O; Bachmann A; Seitz M; Stief CG
MMW Fortschr Med; 2005 Oct; 147(41):45. PubMed ID: 16270512
[No Abstract] [Full Text] [Related]
5. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
Roth B; Studer UE; Fowler CJ; Kessler TM
J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
[TBL] [Abstract][Full Text] [Related]
6. [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia].
Höfner K; Bach T; Berges R; Dreikorn K; Gratzke C; Madersbacher S; Michel MS; Muschter R; Oelke M; Reich O; Tschuschke C; Bschleipfer T
Urologe A; 2016 Feb; 55(2):184-94. PubMed ID: 26518303
[TBL] [Abstract][Full Text] [Related]
7. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
Kaplan SA
J Urol; 2005 Sep; 174(3):1011. PubMed ID: 16094031
[No Abstract] [Full Text] [Related]
8. [Revised thinking in benign prostatic hyperplasia syndrome].
Höfner K
MMW Fortschr Med; 1999 Aug; 141(33):42-3. PubMed ID: 10766541
[No Abstract] [Full Text] [Related]
9. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
[TBL] [Abstract][Full Text] [Related]
10. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
11. Tailoring treatment in benign prostatic hyperplasia management.
de la Rosette JJ
Curr Opin Urol; 2009 Jan; 19(1):1-2. PubMed ID: 19057208
[No Abstract] [Full Text] [Related]
12. Management of benign prostatic hyperplasia by family physicians.
Toguri A; Barkin J
Can J Urol; 2010 Feb; 17 Suppl 1():26-34. PubMed ID: 20170598
[TBL] [Abstract][Full Text] [Related]
13. Assessment, diagnosis and management of lower urinary tract symptoms in men.
Brown CT; Das G
Int J Clin Pract; 2002 Oct; 56(8):591-603. PubMed ID: 12425369
[TBL] [Abstract][Full Text] [Related]
14. [Benign prostatic hyperplasia. Therapeutic possibilities].
Pannek J; Haupt G; Schulze H
Med Monatsschr Pharm; 1994 Aug; 17(8):237-46. PubMed ID: 7523841
[No Abstract] [Full Text] [Related]
15. [Epidemiology and diagnosis of benign prostata hyperplasia].
Schlenker B; Seitz M; Reich O; Stief CG; Gratzke C
MMW Fortschr Med; 2009 Oct; 151(41):31-2. PubMed ID: 19891181
[No Abstract] [Full Text] [Related]
16. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
[No Abstract] [Full Text] [Related]
17. Enlarged prostate gland. Many treatment options.
Mayo Clin Health Lett; 2001 Apr; 19(4):1-3. PubMed ID: 11284232
[No Abstract] [Full Text] [Related]
18. Editorial: benign prostatic hyperplasia.
Djavan B
Curr Opin Urol; 2013 Jan; 23(1):1. PubMed ID: 23202284
[No Abstract] [Full Text] [Related]
19. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
[TBL] [Abstract][Full Text] [Related]
20. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
Gotoh M
Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
